Formation
1994
501(c)3
All Rise is the training, membership, and advocacy organization for justice system innovation addressing substance use and mental health at every intercept point.
Carson Fox
About[edit]
All Rise is the leading training, membership, and advocacy organization for advancing justice system responses to individuals with substance use and mental health disorders. All Rise impacts every stage of the justice system, from first contact with law enforcement to corrections and reentry, and works with public health leaders to improve treatment outcomes for justice-involved individuals. Through its four divisions—the Treatment Court Institute, Impaired Driving Solutions, Justice for Vets, and the Center for Advancing Justice—All Rise provides training and technical assistance at the local and national level, advocates for federal and state funding, and collaborates with public and private entities. All Rise works in every U.S. state and territory and in countries throughout the world.
Founded as the National Association of Drug Court Professionals (NADCP) in 1994, All Rise has been at the forefront of justice system transformation for nearly three decades. As the leader of the treatment court movement, All Rise helps prove that a combination of evidence-based treatment and accountability is the most effective justice system response to individuals with substance use and mental health disorders. All Rise has trained over 800,000 public health and public safety professionals, and the number of treatment courts in the United States has grown to more than 4,000, helping more than 1.5 million people access treatment.[2]
Divisions[edit]
All Rise operates its training and technical support services through four divisions:[3]
The Treatment Court Institute leads training, technical assistance, and research dissemination for more than 4,000 treatment court programs.
Impaired Driving Solutions uplifts communities by delivering curated solutions to eliminate impaired driving.
Justice for Vets transforms how the justice system identifies, assesses, and treats our veterans.
The Center for Advancing Justice empowers emerging justice system innovations to address substance use and mental health and promote recovery.
Controversy[edit]
While Karen Freeman-Wilson was CEO of NADCP she helped get a trial of Gabasync (Prometa), a combination of flumazenil, hydroxyzine, and the psychoactive drug gabapentin, promoted as treatment for methamphetamine addiction, launched in the Gary, Indiana drug court despite not having clinical trials or FDA approval.[7] She then took a job offer to be on the board of directors at Hythiam, the company marketing Prometa that was owned by convicted fraudster Terren Peizer. Hythiam charged up to $15,000 for treatment that was split between Hythiam and physicians.[8][9] Clinical trials funded by Hythiam and performed by the UCLA found Gabasync to be ineffective for the treatment of addictions.[10]